The Correlation Between Outcome and Infarct Growth in Patients With Acute Ischemic Stroke
NCT ID: NCT01376609
Last Updated: 2011-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2011-08-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis in Subacute Ischemic Stroke Using Multimodal Imaging
NCT06289036
A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients
NCT02024503
Brain MRI in Stroke Patients With Intracardiac Thrombus
NCT04456309
MRI-SWI as a Predictor of Functional Outcome in Acute Ischemic Stroke
NCT00696306
Medical Imaging Screening for Posterior-circulation Ischemic Stroke
NCT06094569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute middle cerebral artery ischemic stroke
* Stroke onset within 48 hours
* Included a complete set of initial MR images and final outcome MR images up to 1 months
Exclusion Criteria
* Pre-existing neurological or psychiatric disease that could confound the study results such as a pre-stroke mRS score greater than 3
* CT evidence of the following conditions before enrollment:
Significant mass effect with midline shift Evidence of intracranial hemorrhage
* With contraindication to MR such as severe allergy to contrast media
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing University of Chinese Medicine
OTHER
Beijing Hospital of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dept.of Neurology,Beijing Dongfang Hospital, Beijing University of Chinese Traditional Medicine,Beijing,China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jianghai Ruan
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BUCM-002H-ND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.